Addiction is such a common problem today that people experiencing alcohol, nicotine or other drug problems present in many different healthcare settings. The challenge of linking people experiencing addiction to the right response is a serious one, and much depends on understanding addiction and recognising the role that we all play in the pathway to recovery.
This course is intended to help you meet this challenge by increasing your understanding of the biology of addiction and the available treatment options in the different stages of the recovery journey.
Key questions we will look at in this course include:
- When do we call “excessive use” addiction?
- Why is it so difficult to change addictive behaviour?
- Who can play a role to get people on the track to recovery?
- How do you respond to people with mild to moderate problems?
- How can you assess and increase motivation to change?
- What sort of interventions can support a person experiencing severe addiction?
- What is my role as a professional, either within or outside of addiction care?
- How can I identify the best of the many options available?
- What are hurdles to get the right support to manage addiction around the world?
This course explores the “Recovery Pathway,” an easy-to-use framework for helping people with addiction move successfully from addiction to recovery. It helps plan a pathway through screening and assessment, to withdrawal and long-term relapse prevention. The course will examine a range of psychosocial interventions and medication-assisted treatments. You will review the biological basis of behaviour and treatment related to the stage of recovery, as well as evidence-based and service delivery considerations. This course is an ideal starting-point for healthcare professionals who want to get to grips with effective approaches to treating addiction.
- Framework for pathways to recovery
- How to identify people at risk of addiction
- Applied understanding of intervention and treatment options
Dr Femke Buisman-Pijlman is a leader in Addiction Studies and online education. She is an award-winning teacher and researcher in the Discipline of Pharmacology at the University of Adelaide, where she is a Senior Lecturer Addiction Studies and head of the Behavioural Neuroscience lab. As program leader of the International Programme in Addiction Studies, and other postgraduate degrees in Alcohol and Drug Studies, she has taught the biology of addiction and treatment options to a wide range of students. Femke is also the convenor of the major in Addiction and Mental Health which has recently been introduced to the Bachelor of Health and Medical Sciences at the University of Adelaide.
Femke has extensive experience teaching fully online programs to professionals in the field from all around the world. She has extensive experience working in the interdisciplinary field of addiction. Currently, Femke’s research is demonstrating how early life experiences affect behaviour and susceptibility to addiction. Since 2008, Femke has been Graduate Affiliate Faculty at Virginia Commonwealth University. Femke is postgraduate coordinator for Pharmacology and passionate about engaging kids in neuroscience.
Associate Professor Robert Ali is a public health physician and specialist in addiction medicine who is passionate about training professionals in the field from around the world. He is the Director of a World Health Organization Collaborating Centre for Research into the Treatment of Drug and Alcohol Problems at the University of Adelaide and has recently retired from his position as the Director of Community Based Treatments at the Drug and Alcohol Services South Australia.
Robert is a member of the Australian National Advisory Council on Alcohol and Drugs, member of the Cochrane Alcohol and Drug Group editorial board and the WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems. Robert is also active in teaching undergraduate medical students and online training.
Robert has chaired several reviews of the national methadone and/or buprenorphine policies. He was the lead researcher in South Australia for the National Evaluation of Pharmacotherapies for Opioid Dependence.